Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Cold Agglutinin Disease: Virtual Patient Simulation Improves Performance in Diagnosis and Management

S Christy Rohani-Montez, Michelle Arielle Worst, Stephanie Baumhover, Alyssa Mitarotondo, Emily Mikhael, Sigbjørn Berentsen, Roy Smith

Blood (2024) 144 (Supplement 1): 2444.

https://doi.org/10.1182/blood-2024-207690

Published: 2024

Journal Articles

Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia

Catherine M. Broome, Alexander Röth, MD, David J. Kuter, MD, Marie Scully, MD, Roy Smith, Jennifer Wang, Xiaoyu Jiang, Caroline Reuter, Ahmed Daak, William Hobbs

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-139663

Published: 2020

Journal Articles

Inhibition of the Classical Pathway of Complement with Sutimlimab in Chronic Immune Thrombocytopenic Purpura Patients without Adequate Response to Two or More Prior Therapies

Catherine M Broome, MD, Alexander Röth, MD PhD, David J. Kuter, Marie Scully, Roy Smith, Jennifer Wang, Caroline Reuter, William Hobbs

Blood (2019) 134 (Supplement_1): 898.

https://doi.org/10.1182/blood-2019-122210

Published: 2019

Journal Articles

Analysis of Patients Mislabeled with Heparin Induced Thrombocytopenia

Apurva Pandey, MD, Christine Ann Garcia, MD MPH, Roy Smith, MD

Blood (2017) 130 (Supplement 1): 3619.

https://doi.org/10.1182/blood.V130.Suppl_1.3619.3619

Published: 2017

Journal Articles

Thirty Day Readmissions Due to Venous Thromboembolism in Patients Discharged with Syncope

Sudeep K Siddappa Malleshappa, MD, Kathan Dilipbhai Mehta, MBBS, MPH, Gautham K Velecha, MBBS, Smit Patel, MBBS, MPH, Smith Giri, MBBS, Roy Smith, MD, Rahul Atul Parikh, MD PhD

Blood (2017) 130 (Supplement 1): 4642.

https://doi.org/10.1182/blood.V130.Suppl_1.4642.4642

Published: 2017

NARROW

Cold Agglutinin Disease: Virtual Patient Simulation Improves Performance in Diagnosis and Management

Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia

Inhibition of the Classical Pathway of Complement with Sutimlimab in Chronic Immune Thrombocytopenic Purpura Patients without Adequate Response to Two or More Prior Therapies

Analysis of Patients Mislabeled with Heparin Induced Thrombocytopenia

Thirty Day Readmissions Due to Venous Thromboembolism in Patients Discharged with Syncope

Email alerts

ASH Publications

American Society of Hematology

Cold Agglutinin Disease: Virtual Patient Simulation Improves Performance in Diagnosis and Management

Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia

Inhibition of the Classical Pathway of Complement with Sutimlimab in Chronic Immune Thrombocytopenic Purpura Patients without Adequate Response to Two or More Prior Therapies

Analysis of Patients Mislabeled with Heparin Induced Thrombocytopenia

Thirty Day Readmissions Due to Venous Thromboembolism in Patients Discharged with Syncope

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only